Early Onset Cancer Precision Care
Rising in patients under 50, early-onset cancers deserve precision care — Appleglc.com offers targeted therapy insights, genetic counselling resources, and patient-focused oncology support.
Keytruda
Pembrolizumab
Opdivo
Nivolumab
Avastin
Bevacizumab
Mvasi
Bevacizumab-awwb
Zirabev
Bevacizumab-bvzr
Herceptin
Trastuzumab
Enhertu
Fam-Trastuzumab Deruxtecan-nxki
Kadcyla
Ado-trastuzumab Emtansine
Perjeta
Pertuzumab
Tykerb
Lapatinib
Taxol
Paclitaxel
Taxotere
Docetaxel
Abraxane
Paclitaxel Protein-Bound Particles
Xeloda
Capecitabine
Adrucil
Fluorouracil Injection
Eloxatin
Oxaliplatin
Camptosar
Irinotecan Hydrochloride
Platinol
Cisplatin
Paraplatin
Carboplatin
Gemzar
Gemcitabine Hydrochloride
Vitrakvi
Larotrectinib Sulfate
Rozlytrek
Entrectinib
Retevmo
Selpercatinib
Gavreto
Pralsetinib
Lumakras
Sotorasib
Krazati
Adagrasib
Rybrevant
Amivantamab-vmjw
Augtyro
Repotrectinib
Tabrecta
Capmatinib
Tepmetko
Tepotinib
Tecentriq
Atezolizumab
Imfinzi
Durvalumab
Bavencio
Avelumab
Libtayo
Cemiplimab-rwlc
Opdualag
Nivolumab and Relatlimab-rmbw
Ibrance
Palbociclib
Kisqali
Ribociclib
Verzenio
Abemaciclib
Lynparza
Olaparib
Zejula
Niraparib